Researches

We aspire to utilize oligonucleotides loaded LNPs for in vivo reprograming of leukocytes and thus to design novel immunomodulatory therapeutic approaches for autoimmune disorders and cancer.

The goal of this project is to explore resistance pathways of cancer cells and translate the acquired knowledge by designing novel RNAi-based nanotherapeutics.

We aim to utilize RNA-loaded lipid nanoparticles in order to design new therapeutic modalities for various malignancies, including head & neck cancer, glioblastoma and breast cancer.

We aim to design novel platforms for a selective delivery of therapeutic payload to specific target cells, thus increasing the efficiency and reducing adverse effects.

This research aims to broaden the nanotechnology toolbox by designing new, highly efficient, methodologies for nucleic acids delivery.

LeukoTheranostics – Harnessing targeted nanotheranostics to reprogram activated leukocytes in inflammatory bowel disease